4.7 Letter

GPR160 is a potential biomarker associated with prostate cancer

Journal

Publisher

SPRINGERNATURE
DOI: 10.1038/s41392-021-00583-7

Keywords

-

Funding

  1. National Natural Science Foundation of China [81872915, 81673470, 81773792, 81973373]
  2. National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China [2018ZX09735-001, 2018ZX09711002-002-005]
  3. National Key R&D Program of China [2017YFC0114303, 2018YFA0507000]
  4. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020347]
  5. CAS Key Laboratory of Receptor Research External Collaboration Project
  6. Natural Science Foundation of Shanghai Municipality [16ZR1406500]
  7. Guide Project of Science and Technology Commission of Shanghai Municipality [17411963100]
  8. Shanghai Cancer Research Charity Center Fund
  9. Novo Nordisk-CAS Research Fund [NNCAS-2017-1-CC]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available